Image
Accomplishments
Niger stopped mass drug administration (MDA) for lymphatic filariasis in 98% of endemic health districts (HDs); 53 out of 54 HDs as of FY22 (October 2021 – September 2022).
In FY22 (October 2021 – September 2022) Niger developed a plan to address districts with persistent and recrudescent trachoma with the support of Act | West, including twice annual MDA in certain health districts, continued focus on quality MDA implementation, and enhanced monitoring and evaluation strategies.
The national onchocerciasis elimination committee of Niger has determined that the country has successfully eliminated transmission following entomological and epidemiological surveys as of FY21 (October 2020 – September 2021). The country is developing a dossier to be submitted for verification to the World Health Organization. The country is poised to become the first country to eliminate onchocerciasis in Africa.
Standard Disease-Specific Indicators as of FY21
FY21 is October 2020 through September 2021
LYMPHATIC FILARIASIS
of ever-endemic districts have stopped MDA as of FY21
(i.e. have passed stop MDA survey, TAS1 (First Transmission Assessment Survey))
No ever-endemic districts in post-surveillance phase as of FY21
(i.e. have passed last surveillance survey, TAS3 (third Transmission Assessment Survey))
of persons no longer at risk as of FY21 among those who were ever at risk
TRACHOMA
of ever-endemic districts have stopped MDA as of FY21
(i.e. have passed stop MDA survey, TIS (Trachoma Impact Survey))
of ever-endemic districts in post-MDA surveillance phase as of FY21
(i.e. have passed surveillance survey, TSS (Trachoma Surveillance Survey))
of persons no longer at risk as of FY21 among those who were ever at risk
Onchoceriasis
Niger’s government has announced elimination of OV although dossier not yet submitted to WHO.
Schistosomiasis
of ever endemic districts have been treated at least once as of FY21*
*SCH is not supported by USAID
SOIL-TRANSMITTED Helminthiasis
